Literature DB >> 32027742

Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx.

Marcus A Carden1,2, Manila Gaddh3,4, Abhinav Hoskote5, Michael Brown3, Virginia Merrill3, Sean R Stowell6,7, Shanmuganathan Chandrakasan8, Ana Antun3,4, Ragini Kudchadkar3,4, Sarah Kotanchiyev7, David L Jaye3,7, Imre Bodó3,4,9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32027742      PMCID： PMC7013265          DOI： 10.1182/bloodadvances.2019001148

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  25 in total

Review 1.  T follicular helper cell differentiation, function, and roles in disease.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen.

Authors:  Rizwan Ahmed; Zahra Omidian; Adebola Giwa; Benjamin Cornwell; Neha Majety; David R Bell; Sangyun Lee; Hao Zhang; Aaron Michels; Stephen Desiderio; Scheherazade Sadegh-Nasseri; Hamid Rabb; Simon Gritsch; Mario L Suva; Patrick Cahan; Ruhong Zhou; Chunfa Jie; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cell       Date:  2019-05-30       Impact factor: 41.582

3.  Features of Human CD3+CD20+ T Cells.

Authors:  Elisabeth Schuh; Kerstin Berer; Matthias Mulazzani; Katharina Feil; Ingrid Meinl; Harald Lahm; Markus Krane; Rüdiger Lange; Kristina Pfannes; Marion Subklewe; Robert Gürkov; Monika Bradl; Reinhard Hohlfeld; Tania Kümpfel; Edgar Meinl; Markus Krumbholz
Journal:  J Immunol       Date:  2016-07-13       Impact factor: 5.422

4.  Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura.

Authors:  Evaren E Page; Johanna A Kremer Hovinga; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Blood       Date:  2016-04-08       Impact factor: 22.113

Review 5.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2017-08-02       Impact factor: 22.113

6.  FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay.

Authors:  Koichi Kokame; Yuko Nobe; Yoshihiro Kokubo; Akira Okayama; Toshiyuki Miyata
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

7.  Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients.

Authors:  Arumugam Palanichamy; Sarah Jahn; Dorothee Nickles; Mia Derstine; Aya Abounasr; Stephen L Hauser; Sergio E Baranzini; David Leppert; H-Christian von Büdingen
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

8.  Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Julie R Brahmer; Christina Lacchetti; Bryan J Schneider; Michael B Atkins; Kelly J Brassil; Jeffrey M Caterino; Ian Chau; Marc S Ernstoff; Jennifer M Gardner; Pamela Ginex; Sigrun Hallmeyer; Jennifer Holter Chakrabarty; Natasha B Leighl; Jennifer S Mammen; David F McDermott; Aung Naing; Loretta J Nastoupil; Tanyanika Phillips; Laura D Porter; Igor Puzanov; Cristina A Reichner; Bianca D Santomasso; Carole Seigel; Alexander Spira; Maria E Suarez-Almazor; Yinghong Wang; Jeffrey S Weber; Jedd D Wolchok; John A Thompson
Journal:  J Clin Oncol       Date:  2018-02-14       Impact factor: 44.544

9.  Depletion of functionally active CD20+ T cells by rituximab treatment.

Authors:  Esther Wilk; Torsten Witte; Nicole Marquardt; Tibor Horvath; Katy Kalippke; Kirsten Scholz; Nadine Wilke; Reinhold E Schmidt; Roland Jacobs
Journal:  Arthritis Rheum       Date:  2009-12

10.  Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients.

Authors:  Stefan Gingele; Thais Langer Jacobus; Franz Felix Konen; Martin W Hümmert; Kurt-Wolfram Sühs; Philipp Schwenkenbecher; Jonas Ahlbrecht; Nora Möhn; Lars H Müschen; Lena Bönig; Sascha Alvermann; Reinhold E Schmidt; Martin Stangel; Roland Jacobs; Thomas Skripuletz
Journal:  Cells       Date:  2018-12-28       Impact factor: 6.600
View more
  1 in total

1.  CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties.

Authors:  Martijn Vlaming; Vrouyr Bilemjian; Jimena Álvarez Freile; Harm Jan Lourens; Nienke van Rooij; Gerwin Huls; Tom van Meerten; Marco de Bruyn; Edwin Bremer
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.